Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clinical exploration of reversal of diastolic dysfunction
ChiCTR-ONRC-11001636Phase 4Completed
- Sponsor
- Vitup International Hospital
- Start
- Apr 2010
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of phosphocreatine and salvia miltiorrhiza in diastolic dysfunction (2 arms), sponsored by Vitup International Hospital. Primary endpoint: Histology and blood flow Doppler imaging presentation. Started Apr 2010; status: completed.
02
Drugs
phosphocreatinesalvia miltiorrhiza
03
Conditions
diastolic dysfunction
Beyond the preview
Go deeper on ChiCTR-ONRC-11001636.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONRC-11001636.